⌘K

Login Start Free

Home/Filings/4/A/0001645470-20-000002

4/A//SEC Filing

Collier Alan Brian 4/A

Accession 0001645470-20-000002

CIK 0001528172other

View on SEC.gov Company Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 11:56 AM ET

Size

13.8 KB

Accession

0001645470-20-000002

Insider Transaction Report

Form 4/AAmended

Period: 2019-12-10

ENDONOVO THERAPEUTICS, INC.ENDV

Collier Alan Brian

DirectorCEO10% Owner

Transactions

Purchase
Common Stock
2019-12-10$0.00/sh+2,000$6→ 25,414,997 total
Purchase
Common Stock
2019-12-11$0.00/sh+1,000$2→ 25,416,997 total
Purchase
Common Stock
2019-12-10$0.00/sh+1,000$3→ 25,415,997 total
Purchase
Common Stock
2019-12-16$0.00/sh+500$1→ 25,418,597 total
Purchase
Common Stock
2019-12-11$0.00/sh+100$0→ 25,417,097 total
Purchase
Common Stock
2019-12-12$0.00/sh+1,000$2→ 25,418,097 total
Purchase
Common Stock
2019-12-20$1.50/sh+100$150→ 25,519 total

Footnotes (1)

[F1]Reflects a 1000 to 1 reverse split

Documents

1 file

4
primary_doc.xml
PRIMARY DOCUMENT

Issuer

ENDONOVO THERAPEUTICS, INC.

CIK 0001528172

Entity typeother

Related Parties

1

filerCIK 0001645470

Filing Metadata

Form type: 4/A
Filed: Jan 23, 7:00 PM ET
Accepted: Jan 24, 11:56 AM ET
Size: 13.8 KB

View on SEC.gov